Literature DB >> 9259282

PHOG, a candidate gene for involvement in the short stature of Turner syndrome.

J W Ellison1, Z Wardak, M F Young, P Gehron Robey, M Laig-Webster, W Chiong.   

Abstract

The abnormalities seen in Turner syndrome (monosomy X) presumably result from haploinsufficiency of certain genes on the X chromosome. Gene dosage considerations lead to the prediction that the culpable genes escape X inactivation and have functional homologs on the Y chromosome. Among the genes with these characteristics are those residing in the pseudoautosomal regions (PAR) of the sex chromosomes. A pseudoautosomal location for a dosage-sensitive locus involved in stature has been suggested based on the analyses of patients with deletions of a specific segment of the short arm PAR; hemizygosity for this putative locus probably also contributes to the short stature in Turner individuals. We have isolated a gene from the critical deleted region that encodes a novel homeodomain-containing transcription factor and is expressed at highest levels in osteogenic cells. We have named the gene PHOG, for pseudoautosomal homeobox-containing osteogenic gene. Its deletion in patients with short stature, the predicted altered dosage in 45,X individuals, along with the nature of the encoded protein and its expression pattern, make PHOG an attractive candidate for involvement in the short stature of Turner syndrome. We have also found that the mouse homolog of PHOG is autosomal, which may help to explain the lack of a growth abnormality in mice with monosomy X.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9259282     DOI: 10.1093/hmg/6.8.1341

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  62 in total

1.  Two male patients with ring Y: definition of an interval in Yq contributing to Turner syndrome.

Authors:  M Tzancheva; R Kaneva; P Kumanov; G Williams; C Tyler-Smith
Journal:  J Med Genet       Date:  1999-07       Impact factor: 6.318

Review 2.  SHOX mutations.

Authors:  Raymond L Hintz
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

3.  Identification of the first PAR1 deletion encompassing upstream SHOX enhancers in a family with idiopathic short stature.

Authors:  Sara Benito-Sanz; Miriam Aza-Carmona; Amaya Rodríguez-Estevez; Ixaso Rica-Etxebarria; Ricardo Gracia; Angel Campos-Barros; Karen E Heath
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

4.  Strong purifying selection at genes escaping X chromosome inactivation.

Authors:  Chungoo Park; Laura Carrel; Kateryna D Makova
Journal:  Mol Biol Evol       Date:  2010-06-09       Impact factor: 16.240

5.  The role of Shox2 in SAN development and function.

Authors:  Hongbing Liu; Ramón A Espinoza-Lewis; Chaohui Chen; Xuefeng Hu; Yanding Zhang; Yiping Chen
Journal:  Pediatr Cardiol       Date:  2012-02-04       Impact factor: 1.655

Review 6.  Turner syndrome and GH treatment: the state of the art.

Authors:  A M Pasquino
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

7.  A mouse model for human short-stature syndromes identifies Shox2 as an upstream regulator of Runx2 during long-bone development.

Authors:  John Cobb; Andrée Dierich; Yolande Huss-Garcia; Denis Duboule
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

Review 8.  Biglycan knockout mice: new models for musculoskeletal diseases.

Authors:  Marian F Young; Yanming Bi; Laurent Ameye; Xiao-Dong Chen
Journal:  Glycoconj J       Date:  2002 May-Jun       Impact factor: 2.916

9.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

10.  Short Stature in Isodicentric Y Chromosome and Three Copies of the SHOX Gene: Clinical Report and Review of Literature.

Authors:  Angelo Valetto; Veronica Bertini; Angela Michelucci; Benedetta Toschi; Eleonora Dati; Giampietro I Baroncelli; Silvano Bertelloni
Journal:  Mol Syndromol       Date:  2016-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.